Form 4 for WST West Pharmaceutical Services
Accepted 2023-05-31 00:00:00 ET · period of report 2023-05-30 · accession 0001562180-23-004626 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-31 | 2023-05-30 | WST | Winters Chad | VP, CAO | M - OptEx | $241.47 | 0 | 2,321 | New | $0 |
| D | 2023-05-31 | 2023-05-30 | WST | Winters Chad | VP, CAO | M - OptEx | $0.00 | -872 | 456 | -66% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-30 | M | D | 872 | $339.51 | 1,448.71 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-30 | M | A | 872 | $143.43 | 2,320.71 | D | — | — | |
| 3 | Derivative | Stock Options (Right to buy) | 2023-05-30 | M | D | 872 | $0.00 | 456 | D | $143.43 · 2020-10-29 to 2029-10-29 | 872 Common Stock |